How much will Mounjaro cost from September onwards?

What actually changed in September 2025, and why it matters now

Eli Lilly's UK list-price increase on 1 September 2025 was substantial. Before that date, a 15mg Mounjaro pen had a list price of roughly £122; afterwards, the same pen carried a list price of around £330. Private clinics and online pharmacies set their own retail prices above that base, which is why the range you'll see quoted across the market sits broadly between £149 and £375 per four-week pen, varying by dose and provider. Lower doses cost less than the higher maintenance doses, so the number you see advertised for a starter dose often looks quite different from the eventual monthly cost once a prescriber has titrated you upward.

The full story of how and why the price increased is worth reading before you commit to any provider. Eli Lilly cited sustained supply investment and growing demand; whatever the cause, the increase was confirmed in Lilly's August 2025 UK statement and reported widely. If you want a closer look at what the Mounjaro price on 1st September actually meant in practice, that detail is set out clearly for reference. Use the hedged market-range figures above as your reference point when comparing quotes, any provider pricing significantly below the lower end of that range is worth scrutinising carefully.

Mounjaro is a Prescription-Only Medicine licensed for weight management in adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition. More on Mounjaro's licence and clinical profile is available if you're at the stage of deciding whether it's the right treatment for you.

What headline prices from September often leave out

A quoted per-pen price is rarely the whole number. Across the private market, consultation fees, prescription fees and delivery charges are sometimes bundled in and sometimes listed separately. A £10 or £20 monthly delivery charge adds up over a course of treatment that typically runs for months. Aftercare (access to clinical support when you have a question about side effects, or need guidance before a dose review) is often not included in entry-level pricing at all.

It's also worth noting that Mounjaro's monthly cost is not fixed across a course of treatment. Treatment starts at the 2.5mg dose, which exists to let your body adjust rather than to deliver the full therapeutic effect. A prescriber will typically move the dose upward in steps, and prices increase at each step. Many patients find it useful to read about how much Mounjaro will cost in September before budgeting for a full course, since relying on the starter-dose price alone tends to underestimate the actual ongoing cost.

None of this is said to alarm, it's said because transparent arithmetic helps you make a better decision. A full list of what's included and what isn't is worth checking with any provider before you start.

Where nume sits on September pricing, and why we're not the cheapest

We don't compete on being the lowest-priced option. That's a deliberate position, not an oversight. The single price you pay at nume covers the clinical consultation, the GPhC-registered prescriber's review, the prescription, the medicine itself, and free next-working-day tracked delivery, the plain box arrives via DPD with a tracking link, nothing on the outside to indicate what's inside. Seven-day aftercare is included too, as is the clinical re-review before every repeat order. There's no subscription, no auto-renewal and no hidden fees applied at checkout.

Current treatment pricing is shown on our weight-loss treatments page and reflects post-September market costs. We won't print per-pen prices in body copy because they change as doses change, your prescriber sets the dose, the cost follows from that clinical decision, and seeing the full picture at the point of consultation is more useful than a headline number.

Our clinical team reviews every order personally. Our lead prescriber's profile is there if you want to know who's actually making that call.

Why 'cheapest from September' is asking the wrong question

Price is a reasonable starting point for any purchasing decision. For a Prescription-Only Medicine, it's a poor finishing point. Patients often ask how much Mounjaro is going up to in September, and understanding that figure is a sensible first step toward spotting pricing that simply doesn't add up. Mounjaro sold without a proper clinical assessment is Mounjaro supplied outside the law, and the MHRA has documented exactly what that looks like in practice: fake pens reported to the MHRA's Yellow Card scheme, some containing insulin rather than tirzepatide, others containing nothing therapeutic at all. Enforcement through 2025 involved around 20 million doses of illegally traded weight-loss medicines seized, including the first UK site producing counterfeit tirzepatide pens. A price that looks too good relative to the September market range is a signal, not a bargain.

The right question after September 2025 is less about which provider is cheapest and more about which provider gives you genuine medicine, real clinical oversight and actual support if something doesn't feel right. You can verify any online pharmacy on the GPhC pharmacy register in under a minute. That check costs nothing. nume's registration number is 9012878, look it up.

If you'd like to understand how the September increase compares to earlier pricing, the detailed breakdown of Mounjaro prices from September sets that out clearly. When you're ready to find out whether treatment is clinically suitable for you, start your free consultation and a prescriber will review your answers the same day.